On November 16, 2018, the Laboratory Testing Division of Wuxi AppTec opened a new medical device testing center in Suzhou, Jiangsu province of China. This marks the full implementation of WuXi AppTec's medical device testing capabilities in the Chinese market. In conjunction with its existing United States-based medical device testing centers, the new center will help form a globally integrated medical device testing platform. WuXi AppTec will focus its efforts on providing one-stop services from R&D, testing to production and market launch. In addition, it will step up the effort to import international medical devices into China and encourage China’s medical device enterprises to go global by establishing a international exchange channel, as a method to promote global health industry.
Ms. Chen Rong, deputy secretary of Wuzhong District Committee of Suzhou and mayor of Wuzhong District, Mr. Gu Yuqi, member of the Standing Committee of Wuzhong District Committee, deputy secretary of the Party Working Committee of Wuzhong Economic and Technological Development Zone, and deputy director of the Management Committee, Mr. Xu Xing, member of the Standing Committee of Wuzhong District Committee and deputy mayor of Wuzhong District, Mr. Zhang Lin, deputy secretary general of China Association for Medical Devices Industry (CAMDI), Dr. Yang Qing, Executive Vice President and Chief Commercial Officer of WuXi AppTec, Mr. Tong Guodong, Chief Operating Officer of WuXi AppTec and Dr. Liu Fujun, Senior Vice President and Chief Operating Officer of the Laboratory Testing Division of WuXi AppTec delivered a speech respectively and cut the ribbon together at the opening ceremony.
WuXi AppTec (Stock code: 603259) is a leading global company with open-access capability and technology platforms. It aims to provide comprehensive and integrated laboratory R&D and production services consisting of drug discovery, development, marketization for the global pharmaceutical and medical device industry. Prioritizing research and centering on customer, WuXi AppTec seeks to help its worldwide customers shorten the development cycle and lower the cost of drugs and medical device R&D through cost-effective and efficient service platforms. WuXi AppTec platform covers development and production of chemical drugs, research and development of cells and gene therapies, drug development and medical device testing. It is undertaking thousands of innovation programs of more than 3,000 innovative partners from more than 30 countries. Meanwhile, It endeavors to fulfill its dream that “every drug can be made and every disease can be treated” by dedicating to providing the best medicine and best healthcare products to patients worldwide.